Mar 1, 2026

The Memo | Special Edition: Medtech Trailblazers Heading to LSI USA '26

The Memo | Special Edition: Medtech Trailblazers Heading to LSI USA '26

Medtech companies heading to LSI USA 2026, including Fluid Biomed, StimAire, Sandia Medical Technologies, Calla Lily Clinical Care, and Robeauté, among others

Each week in The Memo, we spotlight one emerging medtech company pushing the boundaries of what’s possible in patient care. This week, we’re doing something different. With LSI USA ‘26 just two weeks away, we’re featuring a special edition highlighting a select group of trailblazing companies across five major market segments, all of whom will take the stage in Dana Point.

This is only a snapshot of the companies presenting at LSI USA ‘26, but it offers a compelling preview of the innovation that will be on display.

*Note: All information included in this article is sourced from the LSI USA ‘26 Startup Profiles spreadsheet, Compass AI, and the LSI USA ‘26 Presenting Companies page.

Cardiovascular

Fluid Biomed

Presenter: John Wong

Company Description: Fluid Biomed is developing the world's first bioabsorbable stent to treat brain aneurysms. The company's innovative polymer technology allows physicians the versatility of treating a wider variety of aneurysms more safely and efficiently. 

Stage: Undisclosed

Commercial Status: Clinical (Pre-Revenue)

Strategic Landscape: Boston Scientific, Stryker, Terumo

4C Medical Technologies

Presenter: Saravana Kumar

Company Description: 4C Medical's AltaValve is a supra-annular transcatheter mitral valve replacement (TMVR) system. The AltaValve system is intended to streamline the procedure to replace degenerated mitral valves compared to current solutions.

Stage: Later Stage

Commercial Status: Clinical (Pre-Revenue)

Strategic Landscape: Medtronic, Boston Scientific, Abbott, Edwards

StimCardio Medical (FKA CardiaCare)

Presenter: Amir Soltanianzadeh

Company Description: StimCardio Medical is developing a breakthrough neuromodulation wearable therapy for AFib that combines peripheral neurostimulation with closed-loop, AI-enabled monitoring.

Stage: Series A

Commercial Status: Clinical (Pre-Revenue)

Strategic Landscape: Medtronic, Boston Scientific, Abbott, LivaNova

Retia Medical

Presenter: Marc Zemel

Company Description: Retia develops healthtech AI algorithms for helping guide management of surgical and critically ill patients to improve outcomes. The company's technology has been clinically validated and is used in 65 hospitals. 

Stage: Series B

Commercial Status: Commercial (Revenue >5M)

Strategic Landscape: Fresenius, Masimo, Getinge

Neuro

StimAire

Presenter: Tarek Makansi

Company Description: StimAire's patented technology is an injectable, rice-grain-sized neurostimulator (combined with a small wearable) for treating obstructive sleep apnea, a $30B market. Replacing major surgery with a 15-minute injection is expected to lead to worldwide reimbursement and full market acceptance.

Stage: Series B

Commercial Status: Clinical (Pre-Revenue)

Strategic Landscape: Medtronic, Nihon Kohden, Natus, Novasom

GT Medical Technologies

Presenter: Per Langoe

Company Description: GT Medical's GammaTile Therapy is a targeted approach for delivering radiation to brain tumor cells. The company's technology minimizes complications while optimizing therapeutic efficacy. Placed by a neurosurgeon during resection, GammeTiles provide uniform radiation-source spacing to ensure even dose distribution. 

Stage: Undisclosed

Commercial Status: Commercial (Revenue >10M)

Strategic Landscape: Varian, Accuray, Brainlab, Elekta, IBA

Symphony Robotics

Presenter: Mordechai (Moty) Avisar

Company Description: Symphony Robotics is developing an AI-powered, MRI-guided micro-robotic platform that enables curved, minimally invasive access to deep and complex brain targets unreachable with conventional straight-line neurosurgical tools. 

Stage: Series A

Commercial Status: Clinical (Pre-Revenue)

Strategic Landscape: Medtronic, J&J, Varian, Intuitive Surgical, Brainlab

JelikaLite

Presenter: Katya Sverdlov

Company Description: JelikaLite is developing innovative neuromodulation therapies for pediatric neurological disorders. Its lead product, Cognilum, is an FDA Breakthrough-designated wearable device designed to reduce symptoms of autism spectrum disorder (ASD).  

Stage: Undisclosed

Commercial Status: Clinical (Pre-Revenue)

Strategic Landscape: Boston Scientific

Orthopedics

Sandia Medical Technologies

Presenter: Rick Thomson

Company Description: Sandia Medical Technologies is an emerging orthopedic company that has developed a replacement joint implant for the third most common site for osteoarthritis in the body. The implant, known as ZEPART, replaces the trapezium bone in the carpometacarpal joint, at the base of the thumb. 

Stage: Seed

Commercial Status: Other (Pre-Revenue)

Strategic Landscape: J&J, Smith+Nephew, Stryker, Zimmer Biomet

Spark Spine

Presenter: Luke Diehl

Company Description: Spark Spine is a medical technology company pioneering next-generation orthopedic implants. Using its patented EMP biomaterial, Spark products harvest electricity from the patient’s movement and use it to power unparalleled therapeutic and diagnostic advancements.

Stage: Seed

Commercial Status: Commercial (Pre-Revenue)

Strategic Landscape: J&J, Smith+Nephew, Stryker, Zimmer Biomet, Globus Medical

Vessl Prosthetics

Presenter: Sydney Robinson

Company Description: Vessl is providing a solution for the hundreds of thousands of amputees who struggle to adapt to loss of limb. The company is designing an automatically adjusting prosthetic socket that redistributes pressure around the leg in response to changes in limb size. 

Stage: Seed

Commercial Status: Commercial (Revenue <5M)

Strategic Landscape: Ossur, Ottobock, WillowWood, ARCH Medical Solutions

KiriGenX

Presenter: Jeff Chandler

Company Description: KiriGenX is developing the first bioinductive collagen implant platform purpose-built for early-stage rotator cuff disease at the articular side. The technology delivers a biologic scaffold to support tendon healing in an underserved patient population and is advancing through a 510(k) pathway, with planned expansion into broader tendon repair indications.

Stage: Seed

Commercial Status: Pre-Clinical (Pre-Revenue)

Strategic Landscape: Arthrex, J&J, Stryker, Zimmer Biomet

Women's Health

Calla Lily Clinical Care

Presenter: Lara Zibners

Company Description: Calla Lily Clinical Care has developed Callavid, a leak-free vaginal drug delivery platform that will revolutionize care for women. Initial target indications are in IVF and miscarriage prevention, followed by delivery of live biotherapeutics (LBPs) to reduce antibiotic usage, which contributes to antimicrobial resistance (AMR). 

Stage: Series A

Commercial Status: Clinical (Revenue <5M)
Strategic Landscape: Pfizer, Bayer, Merck

Ouli

Presenter: Hanna Harkawy

Company Description: Ouli is an innovative telemedicine solution that enables cesarean scar therapy at home under remote specialist supervision. The system consists of a device equipped with a functional head that replicates manual scar mobilization techniques used by physiotherapists.

Stage: Seed

Commercial Status: Commercial (Pre-Revenue)
Strategic Landscape: CooperSurgical, Smith+Nephew, Procter & Gamble

Osteoboost Health

Presenter: Laura Yecies

Company Description: Osteoboost is the first and only FDA-cleared, drug-free prescription treatment for low bone density. With a $30B market of 60M patients suffering from osteopenia and osteoporosis, Osteoboost is the first at-home device clinically proven to slow vertebral bone loss by 85%.

Stage: Series A 

Commercial Status: Commercial (Revenue <5M)
Strategic Landscape: Terumo

Noor Sciences

Presenter: Liesl Nel-Themaat

Company Description: Noor Sciences is a company focused on improving IVF success rates through the development of non-invasive technologies. Its core innovation allows for the assessment of Embryo/Oocyte viability, helping clinicians select the most promising candidates for implantation.

Stage: Seed

Commercial Status: Clinical (Pre-Revenue)
Strategic Landscape: Hologic, Vitrolife, Vitromed

Surgical Robotics

Robeauté

Presenter: Joana Cartocci

Company Description: Robeauté is developing a microrobot for novel therapies in hard-to-reach areas of the body. Designed specifically for the brain, at the service of neurosurgeons, the company’s microrobot will be able to freely navigate in other complex regions of the body to perform biopsies, collect precise anatomically localized data, and deliver therapies on site, at the right dosage.

Stage: Series B

Commercial Status: Pre-Clinical (Pre-Revenue)
Strategic Landscape: J&J, Roche, Novartis

LN Robotics

Presenter: Donghee Kim

Company Description: LN Robotics is developing robotic systems and solutions to innovate percutaneous coronary intervention procedures. The platform provides precision, stability, and confidence to achieve better patient outcomes.

Stage: Series C

Commercial Status: Clinical (Revenue <5M)
Strategic Landscape: Medtronic, J&J, Siemens

Agilis Robotics

Presenter: Jason Chan

Company Description: Agilis Robotics is advancing the field of endoluminal surgery with flexible, miniaturized robotic arms designed to navigate complex anatomy within the urinary and gastrointestinal tracts. The company’s proprietary robotic platform integrates seamlessly with standard endoscopes, offering enhanced precision, control, and dexterity.

Stage: Undisclosed

Commercial Status: Clinical (Pre-Revenue)
Strategic Landscape: Medtronic, J&J, Intuitive Surgical

Quantum Surgical

Presenter: Kurt Azarbarzin

Company Description: Quantum Surgical is a pioneering medical robotics and artificial intelligence company that revolutionizes cancer treatment with innovative robotic-assisted solutions for minimally invasive tumor ablation. Its Epione platform is dedicated to the curative and early treatment of cancers. 

Stage: Undisclosed

Commercial Status: Commercial (Revenue >20M)
Strategic Landscape: J&J, Varian, Intuitive Surgical

Join Us at LSI USA ‘26

Each of the companies featured here has been selected to present at LSI USA ‘26, March 16th–20th. Join us in welcoming them to the event in Dana Point, CA, where they will share the latest updates on their technology and development.